Mechanisms involved in the reduction of serum triglycerides in man upon adding unsaturated fats to the normal diet.

Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69

Interaction between marginal zinc and high fat supply on lipid metabolism and growth of weanling rats. Lipids (2011) 0.78

Ribonucleic acid bacteriophage release: requirement for host-controlled protein synthesis. J Virol (1971) 1.13

Sequence homologies between ribosomal and phage RNAs: a proposed molecular basis for RNA phage parasitism. J Mol Biol (1976) 0.96

Heparin and the atherosclerotic process. Pharmacol Rev (1984) 0.90

Discriminative effect of rifampin of RNA replication of various RNA bacteriophages. J Virol (1975) 0.89

Inhibition of ribonucleic acid bacteriophage release from its host by rifampin. J Virol (1971) 0.87

Inhibition of RNA bacteriophage replication by rifampicin. J Mol Biol (1972) 0.84

Studies with the Chandler rotating loop. Evidence that thrombin generation is responsible for the formation of the artificial in vitro thrombi. Thromb Diath Haemorrh (1969) 0.83

The preparation and characterization of ribonucleic acid obtained by direct phenol extraction of intact cells of Escherichia coli from low ionic environment. Biochem Biophys Res Commun (1966) 0.80

Probable physiologic functions of heparin. Fed Proc (1977) 0.80

The conformation of ribonucleic acids in Escherichia coli ribosomes. Inferences from the mode of action of ribonuclease II. Biochem J (1967) 0.80

Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens. Arch Toxicol (2001) 0.78

Heparin and atherosclerosis. A review of old and recent findings. Am Heart J (1980) 0.78

Serum lipemia: an overlooked cause of tissue hypoxia. Cardiology (1983) 0.76

Heparin and atherosclerosis. Monogr Atheroscler (1978) 0.75

Lipid disorders and heart-disease. Lancet (1970) 0.75

Studies on the fate of parental bacteriophage RNA in the host. J Mol Biol (1970) 0.75

Heparin and vascular endothelium. Vasc Surg (1978) 0.75

The effect of cigarette smoking on various clotting time tests. Vasc Dis (1968) 0.75

Ultra-low-dose intravenous heparin. Lancet (1980) 0.75

The flowing clotting time (thrombus formation time) a sensitive test of hypercoagulability. Thromb Diath Haemorrh (1969) 0.75

The clinical use of heparin. Curr Ther Res Clin Exp (1975) 0.75

Cigarette smoking and thrombotic coagulation of human blood. Further in vitro studies. Arch Environ Health (1967) 0.75

Studies of optimal conditions for the measurement of circulating endogenous lipoprotein lipase activity. J Atheroscler Res (1970) 0.75

Heparin: physiology and pathobiology. Pathobiol Annu (1978) 0.75

Heparin and atherosclerosis. Adv Lipid Res (1983) 0.75

Postabsorptive serum triglyceride levels in man after the addition of highly unsaturated fish oils to the diet. Metabolism (1966) 0.75

Heparin, heparin fractions, and the atherosclerotic process. Semin Thromb Hemost (1985) 0.75

The effect of a heparin antagonist on fasting serum triglycerides in man. J Atheroscler Res (1966) 0.75